CPHI vs ROP
China Pharma Holdings Inc (CPHI) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
CPHI currently screens at market cap $29.0M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the CPHI and ROP stock pages for the full models.
Not investment advice.